Literature DB >> 20554705

Mammary gland growth factors: roles in normal development and in cancer.

Nancy E Hynes1, Christine J Watson.   

Abstract

Normal development of the mammary gland proceeds via interactions between the epithelium and the mesenchyme that start during embryogenesis and continue during pubertal outgrowth and differentiation. The function of specific peptide growth factors that bind members of the receptor tyrosine kinase family and the cytokine receptor family are required at each stage. In many cases the peptides are produced in one compartment and act on receptors in the other compartment. One of the striking differences between normal development and cancer is the loss of this cross-talk. Mammary tumor cells often produce a peptide and express the receptor on the same cell leading to autocrine activation of signaling pathways, a mechanism that is characteristic for cancer cells. We will discuss different peptides in the context of normal development and cancer in this review.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554705      PMCID: PMC2908768          DOI: 10.1101/cshperspect.a003186

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  136 in total

Review 1.  The IGF system and breast cancer.

Authors:  D Sachdev; D Yee
Journal:  Endocr Relat Cancer       Date:  2001-09       Impact factor: 5.678

2.  Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation.

Authors:  Yongzhi Cui; Greg Riedlinger; Keiko Miyoshi; Wei Tang; Cuiling Li; Chu-Xia Deng; Gertraud W Robinson; Lothar Hennighausen
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

3.  Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.

Authors:  Xiuqin Zhang; Omar A Ibrahimi; Shaun K Olsen; Hisashi Umemori; Moosa Mohammadi; David M Ornitz
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

4.  The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development.

Authors:  Richard W E Clarkson; Marion P Boland; Ekaterini A Kritikou; Jennifer M Lee; Tom C Freeman; Paul G Tiffen; Christine J Watson
Journal:  Mol Endocrinol       Date:  2005-11-17

5.  Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds.

Authors:  S G Bonnette; D L Hadsell
Journal:  Endocrinology       Date:  2001-11       Impact factor: 4.736

6.  Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction.

Authors:  Donald E White; Natasza A Kurpios; Dongmei Zuo; John A Hassell; Sandra Blaess; Ulrich Mueller; William J Muller
Journal:  Cancer Cell       Date:  2004-08       Impact factor: 31.743

7.  MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer.

Authors:  Vassiliki Theodorou; Melanie A Kimm; Mandy Boer; Lodewyk Wessels; Wendy Theelen; Jos Jonkers; John Hilkens
Journal:  Nat Genet       Date:  2007-04-29       Impact factor: 38.330

8.  Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells.

Authors:  Tianhong Wang; Guilian Niu; Marcin Kortylewski; Lyudmila Burdelya; Kenneth Shain; Shumin Zhang; Raka Bhattacharya; Dmitry Gabrilovich; Richard Heller; Domenico Coppola; William Dalton; Richard Jove; Drew Pardoll; Hua Yu
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

9.  Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5.

Authors:  Weiwen Long; Kay-Uwe Wagner; K C Kent Lloyd; Nadine Binart; Jonathan M Shillingford; Lothar Hennighausen; Frank E Jones
Journal:  Development       Date:  2003-09-03       Impact factor: 6.868

10.  The IL-4/IL-13/Stat6 signalling pathway promotes luminal mammary epithelial cell development.

Authors:  Walid T Khaled; Eliot K C Read; Sandra E Nicholson; Fiona O Baxter; Amelia J Brennan; Paul J Came; Naomi Sprigg; Andrew N J McKenzie; Christine J Watson
Journal:  Development       Date:  2007-07-04       Impact factor: 6.868

View more
  48 in total

1.  The Rho GTPase Cdc42 is required for primary mammary epithelial cell morphogenesis in vitro.

Authors:  Kristi Bray; Cord Brakebusch; Tracy Vargo-Gogola
Journal:  Small GTPases       Date:  2011-09-01

Review 2.  Influence of berry polyphenols on receptor signaling and cell-death pathways: implications for breast cancer prevention.

Authors:  Harini S Aiyer; Anni M Warri; Denzel R Woode; Leena Hilakivi-Clarke; Robert Clarke
Journal:  J Agric Food Chem       Date:  2012-02-22       Impact factor: 5.279

3.  Research resource: progesterone receptor targetome underlying mammary gland branching morphogenesis.

Authors:  Ashlee R Lain; Chad J Creighton; Orla M Conneely
Journal:  Mol Endocrinol       Date:  2013-08-26

4.  Histology and Transcriptome Profiles of the Mammary Gland across Critical Windows of Development in Sprague Dawley Rats.

Authors:  Kalpana Gopalakrishnan; Susan L Teitelbaum; James Wetmur; Fabiana Manservisi; Laura Falcioni; Simona Panzacchi; Federica Gnudi; Fiorella Belpoggi; Jia Chen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-06-28       Impact factor: 2.673

Review 5.  On mammary gland growth factors: roles in normal development and in cancer.

Authors:  Mien-Chie Hung
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-08-01       Impact factor: 10.005

Review 6.  Mammary stroma in development and carcinogenesis.

Authors:  Teruyo Sakakura; Yuka Suzuki; Robert Shiurba
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-04-21       Impact factor: 2.673

7.  Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways.

Authors:  Catherine Ibarra-Drendall; Michelle M Troch; William T Barry; Gloria Broadwater; Emanuel F Petricoin; Julia Wulfkuhle; Lance A Liotta; Siya Lem; Joseph C Baker; Anne C Ford; Lee G Wilke; Carola Zalles; Nicole M Kuderer; Abigail W Hoffman; Melanie Shivraj; Priya Mehta; Jamila Williams; Nora Tolbert; Laurie W Lee; Patrick G Pilie; Dihua Yu; Victoria L Seewaldt
Journal:  Breast Cancer Res Treat       Date:  2011-06-07       Impact factor: 4.872

8.  Histone demethylase jumonji AT-rich interactive domain 1B (JARID1B) controls mammary gland development by regulating key developmental and lineage specification genes.

Authors:  Mike Ran Zou; Jian Cao; Zongzhi Liu; Sung Jin Huh; Kornelia Polyak; Qin Yan
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

9.  Stat5 regulates the phosphatidylinositol 3-kinase/Akt1 pathway during mammary gland development and tumorigenesis.

Authors:  Jeffrey W Schmidt; Barbara L Wehde; Kazuhito Sakamoto; Aleata A Triplett; Steven M Anderson; Philip N Tsichlis; Gustavo Leone; Kay-Uwe Wagner
Journal:  Mol Cell Biol       Date:  2014-01-27       Impact factor: 4.272

10.  Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity.

Authors:  Dan Zhao; Gui Ma; Xiaolin Zhang; Yuan He; Mei Li; Xueying Han; Liya Fu; Xue-Yuan Dong; Tamas Nagy; Qiang Zhao; Li Fu; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2016-04-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.